Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Medical Hemostatic Agents Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Medical Hemostatic Agents Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Gelation Sponge
      • 1.3.3 Oxidized Regenerated Cellulose Based Hemostats
      • 1.3.4 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Medical Hemostatic Agents Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Surgical Centers
      • 1.4.4 Clnics
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Medical Hemostatic Agents Market Size
      • 2.1.1 Global Medical Hemostatic Agents Revenue 2014-2025
      • 2.1.2 Global Medical Hemostatic Agents Sales 2014-2025
    • 2.2 Medical Hemostatic Agents Growth Rate by Regions
      • 2.2.1 Global Medical Hemostatic Agents Sales by Regions 2014-2019
      • 2.2.2 Global Medical Hemostatic Agents Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Medical Hemostatic Agents Sales by Manufacturers
      • 3.1.1 Medical Hemostatic Agents Sales by Manufacturers 2014-2019
      • 3.1.2 Medical Hemostatic Agents Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Medical Hemostatic Agents Revenue by Manufacturers (2014-2019)
      • 3.2.2 Medical Hemostatic Agents Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Medical Hemostatic Agents Market Concentration Ratio (CR5 and HHI)
    • 3.3 Medical Hemostatic Agents Price by Manufacturers
    • 3.4 Key Manufacturers Medical Hemostatic Agents Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Medical Hemostatic Agents Market
    • 3.6 Key Manufacturers Medical Hemostatic Agents Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Gelation Sponge Sales and Revenue (2014-2019)
      • 4.1.2 Oxidized Regenerated Cellulose Based Hemostats Sales and Revenue (2014-2019)
      • 4.1.3 Others Sales and Revenue (2014-2019)
    • 4.2 Global Medical Hemostatic Agents Sales Market Share by Type
    • 4.3 Global Medical Hemostatic Agents Revenue Market Share by Type
    • 4.4 Medical Hemostatic Agents Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Medical Hemostatic Agents Sales by Application

    6 United States

    • 6.1 United States Medical Hemostatic Agents Breakdown Data by Company
    • 6.2 United States Medical Hemostatic Agents Breakdown Data by Type
    • 6.3 United States Medical Hemostatic Agents Breakdown Data by Application

    7 European Union

    • 7.1 European Union Medical Hemostatic Agents Breakdown Data by Company
    • 7.2 European Union Medical Hemostatic Agents Breakdown Data by Type
    • 7.3 European Union Medical Hemostatic Agents Breakdown Data by Application

    8 China

    • 8.1 China Medical Hemostatic Agents Breakdown Data by Company
    • 8.2 China Medical Hemostatic Agents Breakdown Data by Type
    • 8.3 China Medical Hemostatic Agents Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Medical Hemostatic Agents Breakdown Data by Company
    • 9.2 Rest of World Medical Hemostatic Agents Breakdown Data by Type
    • 9.3 Rest of World Medical Hemostatic Agents Breakdown Data by Application
    • 9.4 Rest of World Medical Hemostatic Agents Breakdown Data by Countries
      • 9.4.1 Rest of World Medical Hemostatic Agents Sales by Countries
      • 9.4.2 Rest of World Medical Hemostatic Agents Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Ethicon
      • 10.1.1 Ethicon Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Medical Hemostatic Agents
      • 10.1.4 Medical Hemostatic Agents Product Introduction
      • 10.1.5 Ethicon Recent Development
    • 10.2 Pfizer
      • 10.2.1 Pfizer Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Medical Hemostatic Agents
      • 10.2.4 Medical Hemostatic Agents Product Introduction
      • 10.2.5 Pfizer Recent Development
    • 10.3 Baxter International
      • 10.3.1 Baxter International Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Medical Hemostatic Agents
      • 10.3.4 Medical Hemostatic Agents Product Introduction
      • 10.3.5 Baxter International Recent Development
    • 10.4 C. R. Bard
      • 10.4.1 C. R. Bard Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Medical Hemostatic Agents
      • 10.4.4 Medical Hemostatic Agents Product Introduction
      • 10.4.5 C. R. Bard Recent Development
    • 10.5 The Medicines Company
      • 10.5.1 The Medicines Company Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Medical Hemostatic Agents
      • 10.5.4 Medical Hemostatic Agents Product Introduction
      • 10.5.5 The Medicines Company Recent Development
    • 10.6 Anika Therapeutics
      • 10.6.1 Anika Therapeutics Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Medical Hemostatic Agents
      • 10.6.4 Medical Hemostatic Agents Product Introduction
      • 10.6.5 Anika Therapeutics Recent Development
    • 10.7 Advanced Medical Solutions
      • 10.7.1 Advanced Medical Solutions Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Medical Hemostatic Agents
      • 10.7.4 Medical Hemostatic Agents Product Introduction
      • 10.7.5 Advanced Medical Solutions Recent Development
    • 10.8 Integra LifeSciences
      • 10.8.1 Integra LifeSciences Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Medical Hemostatic Agents
      • 10.8.4 Medical Hemostatic Agents Product Introduction
      • 10.8.5 Integra LifeSciences Recent Development
    • 10.9 B Braun Melsungen
      • 10.9.1 B Braun Melsungen Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Medical Hemostatic Agents
      • 10.9.4 Medical Hemostatic Agents Product Introduction
      • 10.9.5 B Braun Melsungen Recent Development
    • 10.10 Gelita Medical
      • 10.10.1 Gelita Medical Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Medical Hemostatic Agents
      • 10.10.4 Medical Hemostatic Agents Product Introduction
      • 10.10.5 Gelita Medical Recent Development
    • 10.11 Equimedical
    • 10.12 Vascular Solutions
    • 10.13 Marine Polymer Technologies
    • 10.14 Z-Medica
    • 10.15 CryoLife
    • 10.16 BioCer Entwicklungs
    • 10.17 Biom’Up SAS

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Medical Hemostatic Agents Sales Channels
      • 11.2.2 Medical Hemostatic Agents Distributors
    • 11.3 Medical Hemostatic Agents Customers

    12 Market Forecast

    • 12.1 Global Medical Hemostatic Agents Sales and Revenue Forecast 2019-2025
    • 12.2 Global Medical Hemostatic Agents Sales Forecast by Type
    • 12.3 Global Medical Hemostatic Agents Sales Forecast by Application
    • 12.4 Medical Hemostatic Agents Forecast by Regions
      • 12.4.1 Global Medical Hemostatic Agents Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Medical Hemostatic Agents Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Medical Hemostatic Agents is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Medical Hemostatic Agents.

      This report studies the global market size of Medical Hemostatic Agents, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Medical Hemostatic Agents sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Ethicon
      Pfizer
      Baxter International
      C. R. Bard
      The Medicines Company
      Anika Therapeutics
      Advanced Medical Solutions
      Integra LifeSciences
      B Braun Melsungen
      Gelita Medical
      Equimedical
      Vascular Solutions
      Marine Polymer Technologies
      Z-Medica
      CryoLife
      BioCer Entwicklungs
      Biom’Up SAS

      Market Segment by Product Type
      Gelation Sponge
      Oxidized Regenerated Cellulose Based Hemostats
      Others

      Market Segment by Application
      Hospitals
      Surgical Centers
      Clnics
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Medical Hemostatic Agents status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Medical Hemostatic Agents manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Medical Hemostatic Agents are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now